This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Stockwatch Business Reporter
The S&P/TSX Cannabis Index added a fraction to 34.46, while the CSE Composite Index added a fraction to 199.03. Canadian cannabis sales fell for the second month in a row, coming in at $373.2-million in November, according to data released this morning by Statistics Canada. This is down from $390.1-million in October and $392.2-million in August.
The numbers point to a faster-than-expected slowdown in the Canadian cannabis market. This time last year, a common prediction among analysts -- such as CIBC's John Zamparo and ATB Capital's Frederico Gomes -- was that full-year Canadian cannabis sales would land between $4.8-billion and $4.9-billion in 2022. Such forecasts saw several downward revisions over the months as prices dwindled and volumes mellowed. In October, for example, the above Mr. Gomes cut his 2022 forecast to $4.5-billion from $4.7-billion. Even this now looks overly optimistic, with StatsCan showing that sales from January through November came to just $4.0-billion.
The remainder is available to Stockwatch subscribers.
© 2024 Canjex Publishing Ltd. All rights reserved.